Back
Biomarin Pharmaceutical Vs. Pfizer Industry Stock Comparison
Buy
64
BMRN
Biomarin Pharmaceutical
Last Price:
64.87
Seasonality Move:
8.34%
Sell
26
PFE
Pfizer
Last Price:
25.76
Seasonality Move:
0.66%
Buy
64
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $65.09. The Score for BMRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Pfizer (PFE)
is a Sell
Is Pfizer a Buy, Sell or Hold?
- The current Pfizer [PFE] share price is $26.17. The Score for PFE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- PFE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $65.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
PFE Stock Price Chart
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.76 | Sell |
| Relative Strength Index (14 RSI): | 43.34 | Sell |
| Chaikin Money Flow: | 264765 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.82 - 68.94) | Sell |
| Bollinger Bands (100): | (67.7 - 87.1) | Sell |
PFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.86 | Sell |
| Relative Strength Index (14 RSI): | 43.1 | Sell |
| Chaikin Money Flow: | 12120258 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.64 - 28.46) | Sell |
| Bollinger Bands (100): | (27.35 - 29.99) | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.54 | Buy |
| 20-day SMA: | 65.43 | Sell |
| 50-day SMA: | 68.16 | Sell |
| 200-day SMA: | 80.94 | Sell |
| 8-day EMA: | 64.16 | Buy |
| 20-day EMA: | 65.52 | Sell |
| 50-day EMA: | 69.56 | Sell |
| 200-day EMA: | 79.24 | Sell |
PFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.33 | Buy |
| 20-day SMA: | 26.62 | Sell |
| 50-day SMA: | 28.14 | Sell |
| 200-day SMA: | 28.08 | Sell |
| 8-day EMA: | 25.68 | Buy |
| 20-day EMA: | 26.45 | Sell |
| 50-day EMA: | 27.57 | Sell |
| 200-day EMA: | 28.88 | Sell |
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Pfizer Earnings Growth & PFE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.04 per share.
Biomarin Pharmaceutical Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pfizer Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||